Last Updated: June 10, 2026

PONATINIB Drug Patent Profile

Name: PONATINIB Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Ponatinib, and what generic alternatives are available?

Ponatinib is a drug marketed by Apotex and is included in one NDA.

The generic ingredient in PONATINIB is ponatinib hydrochloride. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the ponatinib hydrochloride profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for PONATINIB?
What are the global sales for PONATINIB?
What is Average Wholesale Price for PONATINIB?

Summary for PONATINIB

US Patents:	0
Applicants:	1
NDAs:	1
DailyMed Link:	PONATINIB at DailyMed

Drug patent expirations by year for PONATINIB

US Patents and Regulatory Information for PONATINIB

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apotex	PONATINIB HYDROCHLORIDE	ponatinib hydrochloride	TABLET;ORAL	215893-001	Jul 14, 2023		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Apotex	PONATINIB HYDROCHLORIDE	ponatinib hydrochloride	TABLET;ORAL	215893-002	Jul 14, 2023		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for PONATINIB

Can Ponatinib treat resistant CML?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.